This Study is Mainly About Finding Incidence Among Other Factors of Thyroid Cancer in Patient with Benign Disease As MNG to Early Discover of the Malignancy to Save the Patient from Aggressive Procedure

Launched by ASMAA MOHAMED EMAM · Dec 9, 2024

Keywords

ClinConnect Summary

This clinical trial is designed to understand how common thyroid cancer is in patients who have a condition called multinodular goiter (MNG). When patients with MNG have surgery to remove their thyroid, the study aims to check for any hidden thyroid cancer that might have been missed. By identifying factors related to patients, like their age and health, the researchers hope to find out more about why some patients develop thyroid cancer even when initial tests show they don't have it. This information could help doctors discover cancer earlier and avoid more aggressive treatments.

To participate in this study, patients must be adults who have MNG, normal thyroid function tests, and previous fine needle aspiration cytology (FNAC) results that showed no cancer. Patients who have suspicious nodules on their ultrasound or have had previous thyroid surgery will not be included. The trial is not yet recruiting participants, but once it starts, those who qualify can expect to undergo surgery with careful monitoring for any signs of thyroid cancer. This research is important because it aims to improve the way we detect thyroid cancer in patients who might not show typical signs of the disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or Female patients with multinodular goiter Patients with normal thyroid function tests Patients with FNAC negative for malignancy Patients who are fit for general anesthesia
• Exclusion Criteria:
• • patient suspicious nodule on ultrasound imaging patients in whom distant metastases occurred preoperatively but FNAC was negative for malignancy patients with a history of thyroidectomy Patients with severe comorbid conditions with high risk for general anesthesia